jct@pharmacytoday.co.nz

The prospect of medicinal cannabis products being sold on pharmacy shelves may become a reality as early as next year, following last year’s passing of the Misuse of Drugs (Medicinal Cannabis) Amendment Act. 

Northland pharmacists have until 30 April to have their say on the DHB document that will govern how pharmacy services are contracted and paid for in their region over the next seven years

The date for the reclassification of codeine coming into force will not be 31 January 2020, Medsafe group manager Chris James says

The industry body representing medicines manufacturers is concerned a lack of clarity around the upcoming codeine-containing medicines reclassification may result in a situation like the recent dextromethorphan-containing medicines “shambles”

Using his skills to serve his own people has always been a dream for pharmacist Kevin Pewhairangi

With biological ages 15 years older than their chronological ages and life expectancies cut short by an average of 20 years, opioid substitution patients don’t have easy lives

When Gees Linctus and dextromethorphan-containing medicines were reclassified on 25 February, no one heard about it

From uncovering the stories of pharmacists who served in WWI to digging up annual reports from Pharmaceutical Society meetings held more than 100 years ago, retired Wellington pharmacist Euan Galloway has become the go-to guy for pharmacy history in New Zealand

The latest pharmacy audit results show some improvement, but Medsafe says it is still observing a lower standard of practice than expected

The prospect of medicinal cannabis products being sold on pharmacy shelves may become a reality as early as next year, following last year’s passing of the Misuse of Drugs (Medicinal Cannabis) Amendment Act.